Marc Vrana

454 total citations
12 papers, 369 citations indexed

About

Marc Vrana is a scholar working on Pharmacology, Spectroscopy and Molecular Biology. According to data from OpenAlex, Marc Vrana has authored 12 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Spectroscopy and 4 papers in Molecular Biology. Recurrent topics in Marc Vrana's work include Pharmacogenetics and Drug Metabolism (6 papers), Mass Spectrometry Techniques and Applications (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Marc Vrana is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Mass Spectrometry Techniques and Applications (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Marc Vrana collaborates with scholars based in United States, Sweden and Czechia. Marc Vrana's co-authors include Bhagwat Prasad, Andrea Gaedigk, Deepak Bhatt, Aanchal Mehrotra, Jashvant D. Unadkat, Julia Yue Cui, J. Steven Leeder, Sunny Lihua Cheng, Robin E. Pearce and Theo K. Bammler and has published in prestigious journals such as Analytical Chemistry, The FASEB Journal and Journal of Pharmaceutical Sciences.

In The Last Decade

Marc Vrana

12 papers receiving 368 citations

Peers

Marc Vrana

PHARM

ONCOL

PPCH

PHARM

Hiromitsu Imai Japan

Takehisa Matsumaru Japan

Renato J. Scialis United States

Hisanori Hara Switzerland

Edwin Spaans Netherlands

Kenji Tabata Japan

Melanie N. Tallman United States

Isabelle Walter Switzerland

Ryan Takahashi United States

Katsuhiro Yamano Japan

Hiromitsu Imai Japan

Marc Vrana

164 ×1.3

PHARM

182 ×1.4

ONCOL

109 ×0.9

107 ×1.0

PPCH

87 ×1.4

PHARM

Citations per year, relative to Marc Vrana Marc Vrana (= 1×) peers Hiromitsu Imai

Countries citing papers authored by Marc Vrana

Since Specialization

Citations

This map shows the geographic impact of Marc Vrana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Vrana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Vrana more than expected).

Fields of papers citing papers by Marc Vrana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Vrana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Vrana. The network helps show where Marc Vrana may publish in the future.

Co-authorship network of co-authors of Marc Vrana

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Vrana. A scholar is included among the top collaborators of Marc Vrana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Vrana. Marc Vrana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Vrana, Marc & Bhagwat Prasad. (2019). Tissue-specific mechanisms of irinotecan metabolism. Drug Metabolism and Pharmacokinetics. 34(1). S47–S47. 1 indexed citations

Xu, Meijuan, et al.. (2018). An LC-MS/MS proteomics based methodology to simultaneously evaluate the recovery, enrichment and purity of microsomal and cytosolic fractions isolated from tissues for in vitro drug metabolism studies. Drug Metabolism and Pharmacokinetics. 33(1). S17–S17. 1 indexed citations

Xu, Meijuan, Neha Saxena, Marc Vrana, et al.. (2018). Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies. Analytical Chemistry. 90(20). 11873–11882. 27 indexed citations

Vrana, Marc, et al.. (2017). Database of Optimized Proteomic Quantitative Methods for Human Drug Disposition‐Related Proteins for Applications in Physiologically Based Pharmacokinetic Modeling. CPT Pharmacometrics & Systems Pharmacology. 6(4). 267–276. 17 indexed citations

Prasad, Bhagwat, Marc Vrana, Aanchal Mehrotra, Katherine Johnson, & Deepak Bhatt. (2016). The Promises of Quantitative Proteomics in Precision Medicine. Journal of Pharmaceutical Sciences. 106(3). 738–744. 32 indexed citations

Vrana, Marc, et al.. (2016). An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics. Drug Metabolism and Disposition. 44(10). 1692–1696. 13 indexed citations

Prasad, Bhagwat, Andrea Gaedigk, Marc Vrana, et al.. (2016). Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics. Clinical Pharmacology & Therapeutics. 100(4). 362–370. 113 indexed citations

Mehrotra, Aanchal, Mikael Boberg, Marc Vrana, et al.. (2016). Age‐dependent Expression Analysis of Major Drug Metabolizing Enzymes in Human Liver. The FASEB Journal. 30(S1). 1 indexed citations

Boberg, Mikael, Marc Vrana, Aanchal Mehrotra, et al.. (2016). Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants. Drug Metabolism and Disposition. 45(2). 216–223. 86 indexed citations

10.

Selwyn, Felcy Pavithra, Sunny Lihua Cheng, Theo K. Bammler, et al.. (2015). Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice. Toxicological Sciences. 147(1). 84–103. 75 indexed citations

11.

Kálal, J., et al.. (1990). Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb".. PubMed. 13(1). 34–7. 1 indexed citations

12.

Vrana, Marc, et al.. (1978). Studies of local reactivity to B. pertussis suspensions by means of the rat paw oedema.. PubMed. 22(1). 47–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact